These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 2574862

  • 1. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C.
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D1 and D2 receptor selectivities of agonists and antagonists.
    Seeman P, Ulpian C.
    Adv Exp Med Biol; 1988 Dec; 235():55-63. PubMed ID: 2976254
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K.
    Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7238-41. PubMed ID: 1678519
    [Abstract] [Full Text] [Related]

  • 4. Receptor-receptor link in membranes revealed by ligand competition: example for dopamine D1 and D2 receptors.
    Seeman P, Sunahara RK, Niznik HB.
    Synapse; 1994 May 15; 17(1):62-4. PubMed ID: 8042146
    [Abstract] [Full Text] [Related]

  • 5. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions.
    Farrell CB, Lawlor M, Dunne A, O'Boyle KM.
    J Neurochem; 1995 Sep 15; 65(3):1124-30. PubMed ID: 7643090
    [Abstract] [Full Text] [Related]

  • 6. The benzazepine, SCH 23390, inhibits 3H-NPA binding in mouse brain in vivo.
    Andersen PH, Nielsen EB.
    Acta Pharmacol Toxicol (Copenh); 1986 Oct 15; 59(4):315-8. PubMed ID: 2948372
    [Abstract] [Full Text] [Related]

  • 7. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
    Seeman P, Guan HC, Van Tol HH, Niznik HB.
    Synapse; 1993 Aug 15; 14(4):247-53. PubMed ID: 8248849
    [Abstract] [Full Text] [Related]

  • 8. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellotte WW.
    Neuropsychopharmacology; 1987 Dec 15; 1(1):5-15. PubMed ID: 2908095
    [Abstract] [Full Text] [Related]

  • 9. Dopamine D4 receptors elevated in schizophrenia.
    Seeman P, Guan HC, Van Tol HH.
    Nature; 1993 Sep 30; 365(6445):441-5. PubMed ID: 8413587
    [Abstract] [Full Text] [Related]

  • 10. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
    Joyce JN, Lexow N, Bird E, Winokur A.
    Synapse; 1988 Sep 30; 2(5):546-57. PubMed ID: 2973147
    [Abstract] [Full Text] [Related]

  • 11. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S, Markstein R.
    J Neurochem; 1986 Apr 30; 46(4):1058-67. PubMed ID: 2936868
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
    Andersen PH.
    Eur J Pharmacol; 1988 Jan 27; 146(1):113-20. PubMed ID: 2895008
    [Abstract] [Full Text] [Related]

  • 13. Link between dopamine D1 and D2 receptors in rat and human striatal tissues.
    Seeman P, Tallerico T.
    Synapse; 2003 Mar 15; 47(4):250-4. PubMed ID: 12539197
    [Abstract] [Full Text] [Related]

  • 14. Central D1- and D2-receptor occupancy during antipsychotic drug treatment.
    Wiesel FA, Farde L, Nordström AL, Sedvall G.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 Mar 15; 14(5):759-67. PubMed ID: 1981395
    [Abstract] [Full Text] [Related]

  • 15. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
    O'Boyle KM, Waddington JL.
    Neuropharmacology; 1992 Feb 15; 31(2):177-83. PubMed ID: 1532443
    [Abstract] [Full Text] [Related]

  • 16. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
    Sumiyoshi T, Stockmeier CA, Overholser JC, Thompson PA, Meltzer HY.
    Brain Res; 1995 May 29; 681(1-2):109-16. PubMed ID: 7552267
    [Abstract] [Full Text] [Related]

  • 17. Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus.
    Lillrank SM, Lipska BK, Weinberger DR, Fredholm BB, Fuxe K, Ferré S.
    Neurochem Int; 1999 Mar 29; 34(3):235-44. PubMed ID: 10355490
    [Abstract] [Full Text] [Related]

  • 18. Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients.
    Knable MB, Hyde TM, Herman MM, Carter JM, Bigelow L, Kleinman JE.
    Biol Psychiatry; 1994 Dec 15; 36(12):827-35. PubMed ID: 7893846
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
    Niznik HB, Otsuka NY, Dumbrille-Ross A, Grigoriadis D, Tirpak A, Seeman P.
    J Biol Chem; 1986 Jun 25; 261(18):8397-406. PubMed ID: 3522568
    [Abstract] [Full Text] [Related]

  • 20. Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.
    Reader TA, Molina-Holgado E, Dewar KM.
    Mol Neurobiol; 1992 Jun 25; 6(4):425-50. PubMed ID: 1285933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.